Upharmacia June 2017
PHARMA MARKET NEWS
Filya Zhebrivska Retires as CEO of Farmak
On Jun 30 , 2017 , Filya Zhebrivska left the position of the CEO of Farmak to become the Head of the Supervisory Board of the company . The Board also included four other former top-managers of the company . The Supervisory Board will conduct strategic planning of Farmak ’ s development . According of Mrs . Zhebrivska the main goal for the future is the expansion of external markets with main focus on the European market . Polish trade and marketing company , which was acquired by Farmak last year , is to play important role to achieve this goal . The new CEO of Ukraine ’ s leading pharmaceutical company has become Augustin Dubnicka , former site director at Slovakian Zentiva ( a Sanofi company ). In next 2.5 years , Mr . Dubnicka will have to increase the company ’ s share on local market from 6.5 % to 7.5 % and to enhance the share of export to 40 %.
Filya Zhebrivska held the position of Farmak ’ s CEO since 1995 . She owns the controlling stack in company through the Dutch company FARMAK GROUP N . V .
Medicine Producers of Ukraine joined Medicines for Europe
Association Medicine Producers of Ukraine ( AMPU ) joined association Medicines for Europe , which unites the producers of generic drugs . The member of Medicines for Europe support and develop joint Scientific and technical interests of the pharmaceutical industry , national or European associations and generic producers . The association also promotes the development of relations between the EU and third countries in the pharmaceutical sphere .
The Membership in Medicines for Europe allows developing contacts with the European partners in generic sphere and liaising with professional organizations dealing with healthcare issues .
“ We hope the cooperation with European partners at the new level will contribute to strengthening the potential of drug manufacturers in Ukraine and accelerate integration into the European Community ”, the representative of the AMPU stated . The AMPU includes such Ukrainian companies as Farmak , BCPP , Interchem , Yuria-Pharm , Kusum Pharm , Indar , Sperco Ukraine .
Yuria-Pharm Launched Production of Injection Needles
Ukrainian company Yuria-Pharm has launched production of injection needles at its production site in Cherkassy . The company will use certified raw materials from Europe . The planned production volumes and investments were undisclosed . Herewith , the company plans to export the needles after launching them onto Ukrainian market .
There are about 10 local producers of needles and syringes . However , Yuria-Pharm is the only producer of spinal needles in Ukraine . Yuria-Pharm covers 60 % of needs in infusion solutions in public procurements . In 2016 , it has become # 2 company on the Ukrainian hospital drug market with 7.21 % share .
104 Indian
Production Sites
Proved GMP
Compliance in Ukraine
As on Jun 2017 , 104 pharmaceutical production sites form India have proven their compliance with the GMP standards in Ukraine , the Indian Pharmaceutical Manufacturers Association ( IPMA ) reported . 32 certificates were granted by Ukrainian State Drug Service after the
6 www . upharma-c . com